Chemical industry – Page 99
-
Business
Dow rapped for $1bn tax scheme
Judge opines: ‘tax law deals in economic realities, not legal abstractions’
-
Business
Does chemical regulation boost innovation?
Report suggests that supply of innovation responds to extra demand created by new laws
-
Business
Talk of a $6.6bn deal for Elan
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
-
Business
$595m octreotide deal grabs Roche
Company will get worldwide rights to oral formulation of growth hormone drug
-
Business
Merck resolves Vytorin case for $688m
Investors say the company knew about Enhance trial failure but withheld information
-
Business
BMS sells OTC drugs for $482m
Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
-
CareersToxicologist with pesticides on the brain
Vanessa Fitsanakis’ career in toxicology goes all the way back to the farm where she grew up. Helen Carmichael traces her journey from agriculture to academia
-
Business
Biogen buys Tysabri from Elan for $3.25bn
Elan earns huge cash injection for blockbuster drug
-
News
Small business office chemical industry pawn, watchdog claims
The US Small Business Administration’s little-known Office of Advocacy is accused of trying to dilute efforts to regulate certain chemicals
-
Business
GSK commits to AllTrials data disclosure
Company will begin publishing all clinical study reports
-
BusinessReach reviewed: no change required
But disproportionate cost of compliance for small and medium size companies should be reduced, European commission says
-
BusinessEU proposes neonicotinoid pesticide ban
Clothianidin, thiamethoxam and imidacloprid at centre of debate over declining bee populations
-
Business
Zoetis IPO launches at $2.2bn
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
-
Business
DCD in New Zealand milk
Dicyandiamide poses no food risk but fertiliser companies have suspended sales
-
BusinessUnrest over US gas exports
Dow says exports will increase cost of gas and decrease price stability
-
Business
Sabic invests $500m in new R&D centres
Four centres to be created: two in Saudi Arabia, one in India and one in China
-
OpinionName reactions: how does the label stick?
Derek Lowe investigates the long running tradition of naming reactions after their inventors
-
Business
Allergan buys MAP for $958m
Deal strengthens Allergan’s position in neurology with Levadex for treating migraine